Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group.

J Am Soc Nephrol. 2015 Apr;26(4):976-85. doi: 10.1681/ASN.2014010046. Epub 2014 Nov 7.

PMID:
25381429
2.

Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Iklé D, Villarreal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2014 Nov;66(11):3151-9. doi: 10.1002/art.38788.

3.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.

N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.

4.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheum. 2013 Sep;65(9):2441-9. doi: 10.1002/art.38044.

5.

Limited end-user knowledge of methotrexate despite patient education: an assessment of rheumatologic preventive practice and effectiveness.

Sowden E, Hassan W, Gooden A, Jepson B, Kausor T, Shafait I, Haque S, Brockbank JE, Ley RW, Teh LS.

J Clin Rheumatol. 2012 Apr;18(3):130-3. doi: 10.1097/RHU.0b013e31824e1e63.

PMID:
22426579
6.

Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders.

Jepson B, Granpeesheh D, Tarbox J, Olive ML, Stott C, Braud S, Yoo JH, Wakefield A, Allen MS.

J Autism Dev Disord. 2011 May;41(5):575-88. doi: 10.1007/s10803-010-1075-y.

PMID:
20680427
7.

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Russo AJ, Krigsman A, Jepson B, Wakefield A.

Biomark Insights. 2009 Nov 27;4:181-90.

8.

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C; Denosumab HALT Prostate Cancer Study Group.

N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11.

9.

Low Serum Alpha-Antitrypsin Associated with Anti-PR-3 ANCA in Autistic Children with GI Disease.

Russo AJ, Krigsman A, Jepson B, Wakefield A.

Genomics Insights. 2009 Jun 4;2:1-9. eCollection 2009.

10.

Low serum myeloperoxidase in autistic children with gastrointestinal disease.

Russo AJ, Krigsman A, Jepson B, Wakefield A.

Clin Exp Gastroenterol. 2009;2:85-94. Epub 2009 Aug 11.

11.

Spinach-associated Escherichia coli O157:H7 outbreak, Utah and New Mexico, 2006.

Grant J, Wendelboe AM, Wendel A, Jepson B, Torres P, Smelser C, Rolfs RT.

Emerg Infect Dis. 2008 Oct;14(10):1633-6. doi: 10.3201/eid1410.071341.

12.

Characterization of Shewanella oneidensis MtrC: a cell-surface decaheme cytochrome involved in respiratory electron transport to extracellular electron acceptors.

Hartshorne RS, Jepson BN, Clarke TA, Field SJ, Fredrickson J, Zachara J, Shi L, Butt JN, Richardson DJ.

J Biol Inorg Chem. 2007 Sep;12(7):1083-94. Epub 2007 Aug 14.

PMID:
17701062
13.

Investigation of the redox centres of periplasmic selenate reductase from Thauera selenatis by EPR spectroscopy.

Dridge EJ, Watts CA, Jepson BJ, Line K, Santini JM, Richardson DJ, Butler CS.

Biochem J. 2007 Nov 15;408(1):19-28.

14.

The contribution of bacteroidal nitrate and nitrite reduction to the formation of nitrosylleghaemoglobin complexes in soybean root nodules.

Meakin GE, Bueno E, Jepson B, Bedmar EJ, Richardson DJ, Delgado MJ.

Microbiology. 2007 Feb;153(Pt 2):411-9.

PMID:
17259612
15.

Spectropotentiometric and structural analysis of the periplasmic nitrate reductase from Escherichia coli.

Jepson BJ, Mohan S, Clarke TA, Gates AJ, Cole JA, Butler CS, Butt JN, Hemmings AM, Richardson DJ.

J Biol Chem. 2007 Mar 2;282(9):6425-37. Epub 2006 Nov 27.

16.

The role of Bradyrhizobium japonicum nitric oxide reductase in nitric oxide detoxification in soya bean root nodules.

Meakin GE, Jepson BJ, Richardson DJ, Bedmar EJ, Delgado MJ.

Biochem Soc Trans. 2006 Feb;34(Pt 1):195-6. Review.

PMID:
16417520
17.

Evolution of the soluble nitrate reductase: defining the monomeric periplasmic nitrate reductase subgroup.

Jepson BJ, Marietou A, Mohan S, Cole JA, Butler CS, Richardson DJ.

Biochem Soc Trans. 2006 Feb;34(Pt 1):122-6.

PMID:
16417499
18.

Reductive activation of nitrate reductases.

Field SJ, Thornton NP, Anderson LJ, Gates AJ, Reilly A, Jepson BJ, Richardson DJ, George SJ, Cheesman MR, Butt JN.

Dalton Trans. 2005 Nov 7;(21):3580-6. Epub 2005 Sep 26.

PMID:
16234941
19.

A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.

Fitzgerald DA, Hilton J, Jepson B, Smith L.

Pediatrics. 2005 Oct;116(4):e549-54. Epub 2005 Sep 1.

PMID:
16147970
20.

Tuning a nitrate reductase for function. The first spectropotentiometric characterization of a bacterial assimilatory nitrate reductase reveals novel redox properties.

Jepson BJ, Anderson LJ, Rubio LM, Taylor CJ, Butler CS, Flores E, Herrero A, Butt JN, Richardson DJ.

J Biol Chem. 2004 Jul 30;279(31):32212-8. Epub 2004 May 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk